Literature DB >> 31147553

Paediatric and adult-onset male hypogonadism.

Andrea Salonia1,2, Giulia Rastrelli3, Geoffrey Hackett4, Stephanie B Seminara5, Ilpo T Huhtaniemi6,7, Rodolfo A Rey8, Wayne J G Hellstrom9, Mark R Palmert10,11, Giovanni Corona3,12, Gert R Dohle13, Mohit Khera14, Yee-Ming Chan15,16, Mario Maggi3,17.   

Abstract

The hypothalamic-pituitary-gonadal axis is of relevance in many processes related to the development, maturation and ageing of the male. Through this axis, a cascade of coordinated activities is carried out leading to sustained testicular endocrine function, with gonadal testosterone production, as well as exocrine function, with spermatogenesis. Conditions impairing the hypothalamic-pituitary-gonadal axis during paediatric or pubertal life may result in delayed puberty. Late-onset hypogonadism is a clinical condition in the ageing male combining low concentrations of circulating testosterone and specific symptoms associated with impaired hormone production. Testosterone therapy for congenital forms of hypogonadism must be lifelong, whereas testosterone treatment of late-onset hypogonadism remains a matter of debate because of unclear indications for replacement, uncertain efficacy and potential risks. This Primer focuses on a reappraisal of the physiological role of testosterone, with emphasis on the critical interpretation of the hypogonadal conditions throughout the lifespan of the male individual, with the exception of hypogonadal states resulting from congenital disorders of sex development.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31147553      PMCID: PMC6944317          DOI: 10.1038/s41572-019-0087-y

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  231 in total

1.  Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial.

Authors:  Camilla M Hoyos; Roo Killick; Brendon J Yee; Ronald R Grunstein; Peter Y Liu
Journal:  Clin Endocrinol (Oxf)       Date:  2012-10       Impact factor: 3.478

2.  Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples.

Authors:  Gudrun Schneider; Kathrin Nienhaus; Jörg Gromoll; Gereon Heuft; Eberhard Nieschlag; Michael Zitzmann
Journal:  Am J Geriatr Psychiatry       Date:  2011-03       Impact factor: 4.105

3.  Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness.

Authors:  Romina P Grinspon; María G Ropelato; Patricia Bedecarrás; Nazareth Loreti; María G Ballerini; Silvia Gottlieb; Stella M Campo; Rodolfo A Rey
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

4.  Reversal of idiopathic hypogonadotropic hypogonadism.

Authors:  Taneli Raivio; John Falardeau; Andrew Dwyer; Richard Quinton; Frances J Hayes; Virginia A Hughes; Lindsay W Cole; Simon H Pearce; Hang Lee; Paul Boepple; William F Crowley; Nelly Pitteloud
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

5.  Triglycerides induce leptin resistance at the blood-brain barrier.

Authors:  William A Banks; Alan B Coon; Sandra M Robinson; Asif Moinuddin; Jessica M Shultz; Ryota Nakaoke; John E Morley
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

6.  Sexual dysfunction in subjects with Klinefelter's syndrome.

Authors:  G Corona; L Petrone; F Paggi; F Lotti; V Boddi; A Fisher; L Vignozzi; G Balercia; A Sforza; G Forti; E Mannucci; M Maggi
Journal:  Int J Androl       Date:  2009-09-25

7.  The relation between sex hormone levels, the androgen receptor CAGn-polymorphism and depression and mortality in older men in a community study.

Authors:  Gudrun Schneider; Michael Zitzmann; Jörg Gromoll; Karl Heinz Ladwig; Klaus Berger
Journal:  Psychoneuroendocrinology       Date:  2013-04-17       Impact factor: 4.905

8.  Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.

Authors:  Shehzad Basaria; S Mitchell Harman; Thomas G Travison; Howard Hodis; Panayiotis Tsitouras; Matthew Budoff; Karol M Pencina; Joseph Vita; Connie Dzekov; Norman A Mazer; Andrea D Coviello; Philip E Knapp; Kathleen Hally; Emma Pinjic; Mingzhu Yan; Thomas W Storer; Shalender Bhasin
Journal:  JAMA       Date:  2015-08-11       Impact factor: 56.272

9.  Induction of puberty with human chorionic gonadotropin (hCG) followed by reversal of hypogonadotropic hypogonadism in Kallmann syndrome.

Authors:  Malgorzata M Pierzchlewska; Maciej G Robaczyk; Ida Vogel
Journal:  Endokrynol Pol       Date:  2017-10-12       Impact factor: 1.582

10.  Ascertainment of Testosterone Prescribing Practices in the VA.

Authors:  Guneet K Jasuja; Shalender Bhasin; Joel I Reisman; Dan R Berlowitz; Adam J Rose
Journal:  Med Care       Date:  2015-09       Impact factor: 3.178

View more
  43 in total

1.  Trends in reported male sexual dysfunction over the past decade: an evolving landscape.

Authors:  Edoardo Pozzi; Paolo Capogrosso; Luca Boeri; Walter Cazzaniga; Rayan Matloob; Eugenio Ventimiglia; Davide Oreggia; Nicolò Schifano; Luigi Candela; Costantino Abbate; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2020-07-01       Impact factor: 2.896

Review 2.  Testosterone therapy in children and adolescents: to whom, how, when?

Authors:  Maria Camila Suarez A; Joseph M Israeli; Eliyahu Kresch; Leon Telis; Daniel E Nassau
Journal:  Int J Impot Res       Date:  2022-01-07       Impact factor: 2.896

3.  Testosterone suppression impacts craniofacial growth structures during puberty : An animal study.

Authors:  Caio Luiz Bitencourt Reis; Magali de Fátima Pereira Madureira; Caio Luis Rocha Cunha; Wagner Costa Rossi Junior; Tomaz Henrique Araújo; Alessandra Esteves; Maria Bernadete Sasso Stuani; Christian Kirschneck; Peter Proff; Mírian Aiko Nakane Matsumoto; Erika Calvano Küchler; Daniela Silva Barroso de Oliveira
Journal:  J Orofac Orthop       Date:  2022-02-11       Impact factor: 1.938

Review 4.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

Review 5.  Insights into the Regulation on Proliferation and Differentiation of Stem Leydig Cells.

Authors:  Zhuo-Jie Liu; Yong-Hui Liu; Sheng-Yu Huang; Zhi-Jun Zang
Journal:  Stem Cell Rev Rep       Date:  2021-02-17       Impact factor: 5.739

6.  Association of daily step count and serum testosterone among men in the United States.

Authors:  Francesco Del Giudice; Frank Glover; Federico Belladelli; Ettore De Berardinis; Alessandro Sciarra; Stefano Salciccia; Alex M Kasman; Tony Chen; Michael L Eisenberg
Journal:  Endocrine       Date:  2021-02-12       Impact factor: 3.633

7.  Effects of increasing intake of soybean oil on synthesis of testosterone in Leydig cells.

Authors:  Yu Su; Zhenhua Tian; Xiangyu Qi; Dandan Luo; Luna Liu; Shuang Liu; Dongmei Zheng; Fang Wei; Zhao He; Qingbo Guan
Journal:  Nutr Metab (Lond)       Date:  2021-05-26       Impact factor: 4.169

Review 8.  Advances in stem cell research for the treatment of primary hypogonadism.

Authors:  Lu Li; Vassilios Papadopoulos
Journal:  Nat Rev Urol       Date:  2021-06-29       Impact factor: 14.432

Review 9.  Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction.

Authors:  Shubhadeep Roychoudhury; Saptaparna Chakraborty; Arun Paul Choudhury; Anandan Das; Niraj Kumar Jha; Petr Slama; Monika Nath; Peter Massanyi; Janne Ruokolainen; Kavindra Kumar Kesari
Journal:  Antioxidants (Basel)       Date:  2021-05-24

Review 10.  The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy.

Authors:  Andrea Crafa; Aldo E Calogero; Rossella Cannarella; Laura M Mongioi'; Rosita A Condorelli; Emanuela A Greco; Antonio Aversa; Sandro La Vignera
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.